CIP2A expression predicts recurrences of tamoxifen-treated breast cancer

Baldacchino, S, Wastall, LM, Saliba, C et al. (6 more authors) (2017) CIP2A expression predicts recurrences of tamoxifen-treated breast cancer. Tumour Biology, 39 (10). ISSN 1010-4283

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © The Author(s) 2017. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
Keywords: CIP2A, tamoxifen resistance, immunohistochemistry, tissue microarrays, breast cancer
Dates:
  • Published: 1 October 2017
  • Accepted: 1 July 2017
  • Published (online): 15 October 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Molecular Gastroenterology (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Pathology & Tumour Biology (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 25 Sep 2017 11:12
Last Modified: 23 Nov 2017 09:49
Status: Published
Publisher: SAGE Publications
Identification Number: https://doi.org/10.1177/1010428317722064

Share / Export

Statistics